Lista de obras -

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

scientific article published on 19 September 2018

Accelerating precision medicine in metastatic prostate cancer

artículo científico publicado en 2020

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

artículo científico publicado en 2021

An emerging role for cytopathology in precision oncology.

artículo científico publicado en 2015

Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer

artículo científico publicado en 2024

Biology and evolution of poorly differentiated neuroendocrine tumors

artículo científico publicado en 2017

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

artículo científico publicado en 2016

Common germline-somatic variant interactions in advanced urothelial cancer

artículo científico publicado en 2020

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

artículo científico publicado en 2019

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

artículo científico publicado en 2016

Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression

artículo científico publicado en 2012

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

artículo científico publicado en 2012

Integrative Clinical Genomics of Advanced Prostate Cancer.

artículo científico publicado en 2015

Integrative clinical genomics of advanced prostate cancer

artículo científico publicado en 2015

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

artículo científico publicado en 2017

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

artículo científico publicado en 2011

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

scientific journal article

Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target

artículo científico publicado en 2012

Organoid cultures derived from patients with advanced prostate cancer

artículo científico publicado en 2014

Patient derived organoids to model rare prostate cancer phenotypes.

artículo científico publicado en 2018

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

artículo científico publicado en 2017

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

scientific article published on 01 July 2019

Punctuated evolution of prostate cancer genomes

artículo científico publicado en 2013

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

artículo científico publicado en 2021

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

artículo científico publicado en 2020

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer

artículo científico publicado en 2017

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

artículo científico publicado en 2021

Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer

artículo científico publicado en 2021

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

artículo científico publicado en 2021

The long tail of oncogenic drivers in prostate cancer.

artículo científico publicado en 2018

Towards precision oncology in advanced prostate cancer

artículo científico publicado en 2019

Transcriptional mediators of treatment resistance in lethal prostate cancer

artículo científico publicado en 2021

Unraveling the clonal hierarchy of somatic genomic aberrations.

artículo científico publicado en 2014

Lista de obras de

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

Accelerating precision medicine in metastatic prostate cancer

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

An emerging role for cytopathology in precision oncology.

Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer

Biology and evolution of poorly differentiated neuroendocrine tumors

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

Common germline-somatic variant interactions in advanced urothelial cancer

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

Integrative Clinical Genomics of Advanced Prostate Cancer.

Integrative clinical genomics of advanced prostate cancer

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target

Organoid cultures derived from patients with advanced prostate cancer

Patient derived organoids to model rare prostate cancer phenotypes.

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

Punctuated evolution of prostate cancer genomes

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

The long tail of oncogenic drivers in prostate cancer.

Towards precision oncology in advanced prostate cancer

Transcriptional mediators of treatment resistance in lethal prostate cancer

Unraveling the clonal hierarchy of somatic genomic aberrations.